Physicians

This poster is intended for clients; if conditions of tuberculosis (TB) symptoms last more than 2-3 weeks avoid group settings and see a medical provider immediately. 

This poster is intended to encourage health care workers to advise clients that if conditions of tuberculosis (TB) symptoms last more than 2-3 weeks, to avoid group settings and see a medical provider immediately. 

This poster is intended to encourage health care workers to advise clients that if conditions of tuberculosis (TB) symptoms last more than 2-3 weeks, to avoid group settings and see a medical provider immediately. 

This video instructs contact investigators on how to work with healthcare professionals to provide tuberculosis (TB) treatment.

This video describes the process of Directly Observed Therapy (DOT) so that clinicians, nurses, and other health care professionals are aware of how to observe individuals receiving tuberculosis (TB) treatment. 

This toolkit provides background information on Video Directly Observed Therapy (VDOT) and instructs healthcare professionals on how to observe tuberculosis (TB) patients taking their medication remotely. 

This factsheet provides clinicians and public health educators with ways to increase tuberculosis (TB) treatment by overcoming patient-related barriers  through the use of incentives and enablers.

This webinar brings together clinicians, academics, researchers, advocates, professional societies, regulatory agencies and industry representatives to align on best practices to improve treatment for HCV in pregnancy. The TiP-HepC Community of Practice is intended for all stakeholders involved in the care of hepatitis C infection in pregnancy.

This guide provides clinicians with an overview of drug-resistant tuberculosis. The guide includes tools that can be used by providers who participate in the management of patients with drug-resistant TB.

This fact sheet aims to provide clinicians with general information on the presence of nitrosamine impurities found in rifampin and rifapentine and its impact on the treatment for TB.